Many lncRNAS have also been implicated in the control of metastasis, apoptosis and drug resistance including MALAT1 which has been shown to be prognostic in early-stage lung adenocarcinoma and HOTAIR[49] which correlates with poor outcome and metastases in breast cancer [50] and nasopharyngeal carcinoma [51] and tumour recurrence in hepatocellular carcinoma [11]. Here, MALAT1 is linked to lung adenocarcinoma.